WO2024184727 - ALPHA-AMYLASE VARIANTS
National phase entry is expected:
Publication Number
WO/2024/184727
Publication Date
12.09.2024
International Application No.
PCT/IB2024/051877
International Filing Date
27.02.2024
Title **
[English]
ALPHA-AMYLASE VARIANTS
[French]
VARIANTS D'ALPHA-AMYLASE
Applicants **
DANSTAR FERMENT AG
Poststrasse 30
CH-6300 Zug, CH
Inventors
ARGYROS, Aaron
c/o Mascoma LLC,
67 Etna Road #200
Lebanon, New Hampshire 03766, US
PANAITIU, Alexandra-Elena
c/o Mascoma LLC,
67 Etna Road #200
Lebanon, New Hampshire 03766, US
WOODBREY, Anne K.
c/o Mascoma LLC
67 Etna Road #200
Lebanon, New Hampshire 03766, US
Priority Data
PCT/IB2023/052263
09.03.2023
IB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1803 | |
| EPO | Filing, Examination | 6946 | |
| Japan | Filing | 535 | |
| South Korea | Filing | 576 | |
| USA | Filing, Examination | 3685 |
Total: 13545 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure concerns variant polypeptides having alpha-amylase activity exhibiting higher enzymatic activity, lower dependence on the presence of a metallic ion, higher thermostability and/or higher resistance to chelation.[French]
La présente invention concerne des polypeptides variants ayant une activité alpha-amylase présentant une activité enzymatique supérieure, une dépendance inférieure à la présence d'un ion métallique, une thermostabilité supérieure et/ou une résistance à la chélation plus élevée.